Blood Glucose Monitoring System Market Size, Trends, Growth, Opportunities 2024-2032 | CGM systems. F. Hoffmann-La Roche Ltd., Abbott, and Dexcom, Inc.,

The global blood glucose monitoring system market size was valued at USD 16.46 billion in 2023. The market is projected to grow from 𝗨𝗦𝗗 𝟭𝟳.𝟮𝟬 𝗯𝗶𝗹𝗹𝗶𝗼𝗻 𝗶𝗻 𝟮𝟬𝟮𝟰 𝘁𝗼 𝗨𝗦𝗗 𝟮𝟳.𝟳𝟯 𝗯𝗶𝗹𝗹𝗶𝗼𝗻 𝗯𝘆 𝟮𝟬𝟯𝟮, exhibiting a 𝗖𝗔𝗚𝗥 𝗼𝗳 𝟲.𝟮% during the forecast period.

The blood glucose monitoring system devices are used by individuals to calculate the glucose levels in their blood. These devices are essential for patients suffering from type 1 and type 2 diabetes. The increasing patient pool requiring regular blood glucose level monitoring due to the increasing prevalence of diabetes among the population globally is expected to drive market expansion.

𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿 𝗪𝗵𝗮𝘁 𝗬𝗼𝘂'𝗿𝗲 𝗠𝗶𝘀𝘀𝗶𝗻𝗴: 𝗚𝗲𝘁 𝗮 𝗙𝗿𝗲𝗲 𝗥𝗲𝗽𝗼𝗿𝘁 (𝗣𝗗𝗙) 𝗦𝗮𝗺𝗽𝗹𝗲: https://www.fortunebusinessinsights.com/enquiry/sample/blood-glucose-monitoring-market-100648

𝗕𝗹𝗼𝗼𝗱 𝗚𝗹𝘂𝗰𝗼𝘀𝗲 𝗠𝗼𝗻𝗶𝘁𝗼𝗿𝗶𝗻𝗴 𝗦𝘆𝘀𝘁𝗲𝗺 𝗠𝗮𝗿𝗸𝗲𝘁 𝗞𝗲𝘆 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁:

• February 2024 - Dexcom, Inc. launched Dexcom ONE+, the latest Continuous Glucose Monitoring (CGM), with an aim to bring powerful, new diabetes management technology to patients in Belgium, Spain, and Poland.
• January 2024 - Abbott with Tandem Diabetes Care, Inc., one of the players focusing on insulin delivery and diabetes technology, launched the t:slim X2 insulin pump with Control-IQ technology, the first automated insulin delivery system to integrate with FreeStyle Libre 2 Plus sensor in the U.S. This helped the company to strengthen its product portfolio.

𝗧𝗼𝗽 𝗖𝗼𝗺𝗽𝗮𝗻𝗶𝗲𝘀 𝗜𝗻 𝗧𝗵𝗲 𝗕𝗹𝗼𝗼𝗱 𝗚𝗹𝘂𝗰𝗼𝘀𝗲 𝗠𝗼𝗻𝗶𝘁𝗼𝗿𝗶𝗻𝗴 𝗦𝘆𝘀𝘁𝗲𝗺 𝗠𝗮𝗿𝗸𝗲𝘁:

• Abbott (U.S.)
• Braun SE (Germany)
• Dexcom, Inc. (U.S.)
• Ascensia Diabetes Care Holdings AG (Switzerland)
• Medtronic (Ireland)
• Hoffmann-La Roche Ltd (Switzerland)
• Terumo Corporation (Japan)
• LifeScan IP Holdings, LLC (U.S.)
• Senseonics (U.S.)

𝗕𝗹𝗼𝗼𝗱 𝗚𝗹𝘂𝗰𝗼𝘀𝗲 𝗠𝗼𝗻𝗶𝘁𝗼𝗿𝗶𝗻𝗴 𝗦𝘆𝘀𝘁𝗲𝗺 𝗠𝗮𝗿𝗸𝗲𝘁 𝗗𝗿𝗶𝘃𝗲𝗿𝘀 & 𝗥𝗲𝘀𝘁𝗿𝗮𝗶𝗻𝘁𝘀:

𝗣𝗿𝗲𝘀𝗲𝗻𝗰𝗲 𝗼𝗳 𝗟𝗮𝗿𝗴𝗲 𝗗𝗶𝗮𝗯𝗲𝘁𝗶𝗰 𝗣𝗼𝗽𝘂𝗹𝗮𝘁𝗶𝗼𝗻 𝘁𝗼 𝗕𝗼𝗼𝘀𝘁 𝗣𝗿𝗼𝗱𝘂𝗰𝘁 𝗔𝗱𝗼𝗽𝘁𝗶𝗼𝗻

The presence of a large diabetic population, which is suffering from insulin-dependent diabetes, along with new product launches by key players and favourable reimbursement, is driving the blood glucose monitoring system market growth.

However, the costs related to the devices, including the cost of sensors, batteries, readers, and other components of the CGM systems and consumables, may hinder the market expansion.

𝗕𝗹𝗼𝗼𝗱 𝗚𝗹𝘂𝗰𝗼𝘀𝗲 𝗠𝗼𝗻𝗶𝘁𝗼𝗿𝗶𝗻𝗴 𝗦𝘆𝘀𝘁𝗲𝗺 𝗠𝗮𝗿𝗸𝗲𝘁 𝗖𝗼𝗺𝗽𝗲𝘁𝗶𝘁𝗶𝘃𝗲 𝗟𝗮𝗻𝗱𝘀𝗰𝗮𝗽𝗲:

𝗞𝗲𝘆 𝗣𝗹𝗮𝘆𝗲𝗿𝘀 𝗔𝗱𝗼𝗽𝘁 𝗡𝗼𝗻-𝗜𝗻𝘃𝗮𝘀𝗶𝘃𝗲 𝗕𝗹𝗼𝗼𝗱 𝗚𝗹𝘂𝗰𝗼𝘀𝗲 𝗠𝗼𝗻𝗶𝘁𝗼𝗿𝘀 𝘁𝗼 𝗖𝗲𝗺𝗲𝗻𝘁 𝗧𝗵𝗲𝗶𝗿 𝗠𝗮𝗿𝗸𝗲𝘁 𝗣𝗼𝘀𝗶𝘁𝗶𝗼𝗻

The blood glucose monitoring system market is consolidated with several market players, such as F. Hoffmann-La Roche Ltd., Dexcom, Inc., and others. These key players are introducing new non-invasive blood glucose monitors to strengthen their position in the market.

𝗕𝗹𝗼𝗼𝗱 𝗚𝗹𝘂𝗰𝗼𝘀𝗲 𝗠𝗼𝗻𝗶𝘁𝗼𝗿𝗶𝗻𝗴 𝗦𝘆𝘀𝘁𝗲𝗺 𝗠𝗮𝗿𝗸𝗲𝘁 𝗥𝗲𝗽𝗼𝗿𝘁 𝗖𝗼𝘃𝗲𝗿𝗮𝗴𝗲:

The report offers:

• Major growth drivers, restraining factors, opportunities, and potential challenges for the market.
• Comprehensive insights into regional developments.
• List of major industry players.
• Key strategies adopted by the market players.
• The latest industry developments include product launches, partnerships, mergers, and acquisitions.

𝗙𝗼𝗿 𝗙𝘂𝗹𝗹 𝗥𝗲𝗽𝗼𝗿𝘁 𝗖𝗼𝘃𝗲𝗿𝗮𝗴𝗲 𝗩𝗶𝘀𝗶𝘁: https://www.fortunebusinessinsights.com/industry-reports/blood-glucose-monitoring-market-100648

𝗕𝗹𝗼𝗼𝗱 𝗚𝗹𝘂𝗰𝗼𝘀𝗲 𝗠𝗼𝗻𝗶𝘁𝗼𝗿𝗶𝗻𝗴 𝗦𝘆𝘀𝘁𝗲𝗺 𝗠𝗮𝗿𝗸𝗲𝘁 𝗦𝗲𝗴𝗺𝗲𝗻𝘁𝘀:

𝗜𝗻𝗰𝗿𝗲𝗮𝘀𝗶𝗻𝗴 𝗘𝗳𝗳𝗼𝗿𝘁𝘀 𝗯𝘆 𝗞𝗲𝘆 𝗣𝗹𝗮𝘆𝗲𝗿𝘀 𝘁𝗼 𝗟𝗮𝘂𝗻𝗰𝗵 𝗡𝗼𝘃𝗲𝗹 𝗣𝗿𝗼𝗱𝘂𝗰𝘁𝘀 𝘁𝗼 𝗗𝗿𝗶𝘃𝗲 𝗖𝗼𝗻𝘁𝗶𝗻𝘂𝗼𝘂𝘀 𝗚𝗹𝘂𝗰𝗼𝘀𝗲 𝗠𝗼𝗻𝗶𝘁𝗼𝗿𝗶𝗻𝗴 (𝗖𝗚𝗠) 𝗦𝗲𝗴𝗺𝗲𝗻𝘁

Based on device type, the market is classified into Continuous Glucose Monitoring (CGM) systems and Self-Monitoring Blood Glucose (SMBG) systems. The Continuous Glucose Monitoring (CGM) systems segment is expected to dominate the market during the forecast period and hold the largest blood glucose monitoring system market share in 2023. The segment's growth is attributed to the surging efforts of key players to develop and launch novel products to boost the devices' adoption.

𝗜𝗻𝘃𝗮𝘀𝗶𝘃𝗲 𝗦𝗲𝗴𝗺𝗲𝗻𝘁 𝗟𝗲𝗮𝗱𝘀 𝘁𝗵𝗲 𝗠𝗮𝗿𝗸𝗲𝘁 𝗢𝘄𝗶𝗻𝗴 𝘁𝗼 𝘁𝗵𝗲 𝗦𝘂𝗿𝗴𝗶𝗻𝗴 𝗨𝘀𝗲 𝗼𝗳 𝗦𝗠𝗕𝗚 𝗗𝗲𝘃𝗶𝗰𝗲𝘀

By type, the market is segmented into non-invasive and invasive. The invasive segment held the dominant market share in 2023 due to the surging use of SMBG devices among diabetic people.

𝗥𝗶𝘀𝗶𝗻𝗴 𝗡𝘂𝗺𝗯𝗲𝗿 𝗼𝗳 𝗣𝗿𝗼𝗱𝘂𝗰𝘁 𝗟𝗮𝘂𝗻𝗰𝗵𝗲𝘀 𝘁𝗼 𝗣𝗿𝗼𝗽𝗲𝗹 𝗪𝗲𝗮𝗿𝗮𝗯𝗹𝗲 𝗦𝗲𝗴𝗺𝗲𝗻𝘁 𝗘𝘅𝗽𝗮𝗻𝘀𝗶𝗼𝗻

Based on modality, the market is classified into wearable and non-wearable. In 2023, the wearable segment dominated the market in terms of share owing to the increasing product launches that further raised the adoption of these devices among the patient population.

𝗧𝘆𝗽𝗲 𝟮 𝗗𝗶𝗮𝗯𝗲𝘁𝗲𝘀 𝗦𝗲𝗴𝗺𝗲𝗻𝘁 𝘁𝗼 𝗟𝗲𝗮𝗱 𝘁𝗵𝗲 𝗠𝗮𝗿𝗸𝗲𝘁 𝗗𝘂𝗲 𝘁𝗼 𝗟𝗮𝗿𝗴𝗲𝗿 𝗣𝗮𝘁𝗶𝗲𝗻𝘁 𝗣𝗼𝗽𝘂𝗹𝗮𝘁𝗶𝗼𝗻

By patient type, the market is segmented into type 1 diabetes and type diabetes. The type 2 diabetes segment accounted for the dominant market share in 2023 due to the larger patient population with insulin-independent type 2 diabetes compared to type 1 diabetes.

𝗚𝗿𝗼𝘄𝗶𝗻𝗴 𝗞𝗲𝘆 𝗣𝗹𝗮𝘆𝗲𝗿𝘀 𝗜𝗻𝗶𝘁𝗶𝗮𝘁𝗶𝘃𝗲𝘀 𝘁𝗼 𝗘𝘅𝗽𝗮𝗻𝗱 𝗧𝗵𝗲𝗶𝗿 𝗠𝗮𝗿𝗸𝗲𝘁 𝗣𝗿𝗲𝘀𝗲𝗻𝗰𝗲 𝗣𝗿𝗼𝗽𝗲𝗹𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 𝗚𝗿𝗼𝘄𝘁𝗵

Based on the distribution channel, the market is divided into institutional sales and retail sales. In 2023, the market was dominated by the retail sales segment owing to the rising initiatives by the major market players for expanding their market presence via retail channels in the developed and emerging nations.

Geographically, the market for blood glucose monitoring systems is studied across North America, Europe, Asia Pacific, and the rest of the world.

𝗕𝗹𝗼𝗼𝗱 𝗚𝗹𝘂𝗰𝗼𝘀𝗲 𝗠𝗼𝗻𝗶𝘁𝗼𝗿𝗶𝗻𝗴 𝗦𝘆𝘀𝘁𝗲𝗺 𝗠𝗮𝗿𝗸𝗲𝘁 𝗥𝗲𝗴𝗶𝗼𝗻𝗮𝗹 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀:

𝗡𝗼𝗿𝘁𝗵 𝗔𝗺𝗲𝗿𝗶𝗰𝗮 𝗛𝗼𝗹𝗱𝘀 𝗟𝗲𝗮𝗱𝗲𝗿𝘀𝗵𝗶𝗽 𝗣𝗼𝘀𝗶𝘁𝗶𝗼𝗻 𝘄𝗶𝘁𝗵 𝗜𝗻𝗰𝗿𝗲𝗮𝘀𝗲𝗱 𝗔𝗱𝗼𝗽𝘁𝗶𝗼𝗻 𝗼𝗳 𝗠𝗲𝗱𝗶𝗰𝗮𝗹 𝗗𝗲𝘃𝗶𝗰𝗲𝘀

In 2023, North America dominated the market for blood glucose monitoring systems and was valued at USD 7.22 billion. The surging adoption of technologically advanced medical devices and the highly developed per capita medical expenses drive market growth across North America.

Asia Pacific is expected to witness significant CAGR owing to the growing interest of diabetic patients in Australia and Japan to monitor their glucose levels regularly.

𝗖𝘂𝘀𝘁𝗼𝗺𝗶𝘇𝗲 𝗧𝗵𝗶𝘀 𝗥𝗲𝗽𝗼𝗿𝘁 𝗔𝗰𝗰𝗼𝗿𝗱𝗶𝗻𝗴 𝗧𝗼 𝗬𝗼𝘂𝗿 𝗖𝗼𝗻𝘃𝗲𝗻𝗶𝗲𝗻𝗰𝗲: https://www.fortunebusinessinsights.com/enquiry/ask-for-customization/blood-glucose-monitoring-market-100648

𝗖𝗼𝗻𝘁𝗮𝗰𝘁 𝗨𝘀:
Fortune Business Insights™ Pvt. Ltd.
9th Floor, Icon Tower,
Baner, Pune-411045,
Maharashtra, India.
Phone:
U.S.: US +1 833 909 2966 (Toll-Free)
UK +44 808 502 0280 (Toll-Free)
APAC +91 744 740 1245
Email: sales@fortunebusinessinsights.com

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

This release was published on openPR.